Evidence map›Paper›PMID 39655301›Full record

ArticleWorld journal of critical care medicine2024

Angiotensin II administration in severe thrombocytopenia and chronic venous thrombosis: A case report.

Ana Vujaklija Brajkovic, Andrej Markota, Luka Bielen, Andro Vujević, Mia Rora, Radovan Radonic

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Vujaklija BrajkovicDepartment of Internal Medicine, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
Andrej MarkotaDepartment of Intensive Internal Medicine, University Medical Centre Maribor, Maribor 2000, Slovenia.
Luka BielenDepartment of Internal Medicine, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
Andro VujevićDepartment of Internal Medicine, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
Mia RoraDepartment of Internal Medicine, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
Radovan RadonicDepartment of Internal Medicine, University Hospital Centre Zagreb, Zagreb 10000, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe initial trials on angiotensin II (AT II) administration indicated a high incidence of thrombocytopenia and thrombosis, as well as a positive correlation between hyperreninemia and response to the medication. CASE SUMMARY: We describe a case of a patient presenting with catecholamine resistant septic shock, thrombocytopenia, deep vein thrombosis, and normal renin concentration who responded immediately to AT II treatment. We observed no worsening of thrombocytopenia and no progression of thrombosis or additional thromboses during treatment.

conclusionOur case underscores the need for individualized assessment of patients for potential therapy with AT II.

Indexed as

Angiotensin IICase reportReninThrombocytopeniaThrombosisVasodilatory shock

Identifiers

PMID39655301
PMCPMC11577538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.